Retinoic%20Acid%20Receptor%20Alpha%20(RARA)%20positive
Showing 26 - 50 of >10,000
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +4 more
- Atezolizumab
- Tretinoin
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 27, 2022
Effect of Drug Trial in Taichung (Nivolumab, all trans retinoic acid)
Completed
- Effect of Drug
- Nivolumab
- all trans retinoic acid
-
Taichung, Please Select, TaiwanChina Medical University Hospital
Jul 28, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Binimetinib
- +5 more
- (no location specified)
Nov 8, 2022
Endometrial Cancer Trial in New Haven (IMGN853)
Recruiting
- Endometrial Cancer
-
New Haven, ConnecticutSmilow Cancer Hospital at Yale New Haven
Aug 10, 2022
High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine, Carboplatin)
Not yet recruiting
- High Grade Ovarian Cancer
- +2 more
- Mirvetuximab soravtansine
- Carboplatin
- (no location specified)
Jul 11, 2022
Breast Cancer Female Trial (All trans-retinoic acid, 13-Cis Retinoic Acid plus Tocopherol, Mifepristone)
Not yet recruiting
- Breast Cancer Female
- All trans-retinoic acid
- +6 more
- (no location specified)
Aug 17, 2021
Healthy Trial (Alcohol, Alcohol+protein, Alcohol+retinol)
Not yet recruiting
- Healthy
- Alcohol
- +3 more
- (no location specified)
Oct 25, 2023
Vestibular Function Disorder Trial in San Antonio (Alpha Lipoic Acid 300mg, Coenzyme Q10 200mg)
Not yet recruiting
- Vestibular Function Disorder
- Alpha Lipoic Acid 300mg
- Coenzyme Q10 200mg
-
San Antonio, TexasUniversity of Texas Health Science Center at San Antonio
Jul 5, 2023
Ischemic Cardiomyopathy, Diabetes Trial in Damanhur (Alpha Lipoic Acid 600 MG Oral Tablet, Placebo Tablet)
Recruiting
- Ischemic Cardiomyopathy
- Diabetes Mellitus
- Alpha Lipoic Acid 600 MG Oral Tablet
- Placebo Tablet
-
Damanhūr, Elbehairah, EgyptDamanhour Teaching Hospital, General Organization for Teaching H
Sep 26, 2023
Metabolic Associated Fatty Liver Disease Trial in Mexico (LUDLEV®300 mg/46.2 mg, Placebo)
Recruiting
- Metabolic Associated Fatty Liver Disease
- LUDLEV®300 mg/46.2 mg
- Placebo
-
Mexico, Veracruz, MexicoAna Delfina Cano Contreras
Jun 12, 2023
Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,
Recruiting
- Glaucoma, Suspect
- Aberration, Corneal Wavefront
- Low dosage selective alpha-2 receptor agonists topical eyedrop
- High dosage selective alpha-2 receptor agonists topical eyedrop
-
Banhā, QA, EgyptAhmed Abdelshafy
Jan 2, 2023
Solid Tumor, Adult Trial in Shanghai, Hangzhou (HF1K16 /Arm 45 mg/m2, HF1K16 /Arm 90 mg/m2, HF1K16 /Arm 120 mg/m2)
Recruiting
- Solid Tumor, Adult
- HF1K16 /Arm 45 mg/m2
- +3 more
-
Shanghai, Shanghai, China
- +2 more
May 23, 2022
Advanced or Metastatic Breast Cancer, ER+ve Advanced or Metastatic Breast Cancer Trial in Worldwide (AZD5363 when combined with
Completed
- Advanced or Metastatic Breast Cancer
- ER+ve Advanced or Metastatic Breast Cancer
- AZD5363 when combined with weekly paclitaxel.
- +2 more
-
Plovdiv, Bulgaria
- +40 more
Dec 23, 2022
Breast Cancer, Perioperative Period, Dexmedetomidine Trial (Dexmedetomidine, Esketamine, Normal saline)
Not yet recruiting
- Breast Cancer
- +4 more
- Dexmedetomidine
- +2 more
- (no location specified)
Feb 7, 2023
Healthy Trial in Petaling Jaya (Serum with low concentration AHA (1% Glycolic acid and Lactic acid) and PGA)
Recruiting
- Healthy
- Serum with low concentration AHA (1% Glycolic acid and Lactic acid) and PGA
-
Petaling Jaya, Selangor, MalaysiaUngku Shahrin Medical Aesthetic Research & Innovation (USMARI) C
Aug 15, 2023
Metastatic Breast Cancer Trial in East Melbourne (BYl719)
Completed
- Metastatic Breast Cancer
-
East Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Aug 11, 2022
Post COVID-19 Anosmia (Loss of Smell) Trial in Foshan, Kafr Ash Shaykh, Riyadh (Aerosolized 13 cis retinoic acid plus Vitamin D,
Not yet recruiting
- Post COVID-19 Anosmia (Loss of Smell)
- Aerosolized 13 cis retinoic acid plus Vitamin D
- +2 more
-
Foshan, Guangdong, China
- +2 more
Nov 9, 2021
Breast Cancer. Real Clinical Practice in Russia
Recruiting
- Breast Cancer
- Neoadjuvant Endocrine Therapy
- Tamoxifen 20mg
- +4 more
-
Moscow, Russian FederationBlokhin's Russian Cancer Research Center
Apr 5, 2023
DiabetesType 1 Trial (Placebo, Alpha Lipoic Acid 600 MG Oral Capsule)
Not yet recruiting
- Diabetes MellitusType 1
- Placebo
- Alpha Lipoic Acid 600 MG Oral Capsule
- (no location specified)
Jan 8, 2023
ERT in Pompe Disease: Elucidation of Molecular Structures
Not yet recruiting
- Pompe-Disease
-
Rüsselsheim, Hessen, GermanyCentre for Analytical Biochemistry
Jan 30, 2023
Inherited Retinal Dystrophy Primarily Involving Sensory Retina Trial (Disulfiram 250 mg, Placebo)
Not yet recruiting
- Inherited Retinal Dystrophy Primarily Involving Sensory Retina
- Disulfiram 250 mg
- Placebo
- (no location specified)
Nov 22, 2022
Irisin/FNDC5 Single Nucleotide Polymorphism in Breast Cancer
Not yet recruiting
- Breast Cancer
- Genotyping
-
Sohag, EgyptSohag university Hospital
May 17, 2023
Ulcerative Colitis Trial ("Mesalamine" and "alpha-lipoic acid", "Mesalamine" and "Placebo")
Not yet recruiting
- Ulcerative Colitis
- "Mesalamine" and "alpha-lipoic acid"
- "Mesalamine" and "Placebo"
- (no location specified)
Oct 5, 2023